Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 4,002 shares at $49.38 ($198K) on 2021-08-19, disclosed to the SEC on 2021-08-23.
Open-market sale of $198k DNLI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.38 | 1,626 | $80K | 40.5% |
| 2 | $49.38 | 1,626 | $80K | 40.5% |
| 3 | $49.97 | 750 | $37K | 18.9% |
| Total | $49.49 avg | 4,002 | $198K | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $1.5M | — | Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |